-
Innovation Ranking
Innovation Ranking – Jiangsu Hengrui Medicine Co Ltd
Jiangsu Hengrui Medicine Co Ltd (Jiangsu Hengrui) is a biopharmaceutical company that focuses on the research, development, manufacture, and distribution of novel pharmaceutical products. Its product portfolio includes anti-tumor drugs, surgical drugs, contrast agents, angiomyocardiac drugs, and antibiotics. The company is also developing pipeline products for the treatment of cancer, Crohn’s disease, anemia, diabetes, atopic dermatitis, chronic bone disease, blood pressure, and hypercholesterolemia. Jiangsu Hengrui has R&D facilities in China, the US, and Japan. The company offers products through its...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HRS-8427 in Urinary Tract Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HRS-8427 in Urinary Tract Infections report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HRS-8427 in Urinary Tract Infections Drug Details: HRS-8427 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SHR-1819 in Atopic Dermatitis (Atopic Eczema)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SHR-1819 in Atopic Dermatitis (Atopic Eczema) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SHR-1819 in Atopic Dermatitis (Atopic Eczema) Drug Details: SHR-1819...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SHR-1707 in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SHR-1707 in Alzheimer's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SHR-1707 in Alzheimer's Disease Drug Details: SHR-1707 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lutetium 177Lu Oxodotreotide in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lutetium 177Lu Oxodotreotide in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lutetium 177Lu Oxodotreotide in Neuroendocrine Gastroenteropancreatic Tumors...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SHRA-1904 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SHRA-1904 in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SHRA-1904 in Gastric Cancer Drug Details: SHRA-1904 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SHRA-1904 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SHRA-1904 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SHRA-1904 in Solid Tumor Drug Details: SHRA-1904 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SHRA-1904 in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SHRA-1904 in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SHRA-1904 in Pancreatic Cancer Drug Details: SHRA-1904 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Esketamine Hydrochloride in General Anesthetic Effect
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Esketamine Hydrochloride in General Anesthetic Effect report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Esketamine Hydrochloride in General Anesthetic Effect Drug Details: Esketamine...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HTI-1066 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HTI-1066 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HTI-1066 in Solid Tumor Drug Details: HTI-1066 a humanized IgG2, anti-C-Met...